All News
Filter News
Found 808,690 articles
-
Ironwood Announces Updates Designed to Strengthen IW-3718 Phase III Program for Refractory Gastroesophageal Reflux Disease (GERD)
7/21/2020
Changed primary endpoint to continuous from current responder endpoint, in-line with recent FDA guidance and very similar to IW-3718 Phase IIb trial
-
First Commercial Product Using Antares Pharma’s Multi-Dose Pen Platform Launches in Europe
7/21/2020
Antares Pharma, Inc., a pharmaceutical technology company, announced the first commercialization of the Company’s multi-dose pen platform launched in Europe.
-
Trinseo Releases its 10th Annual Sustainability & Corporate Social Responsibility Report
7/21/2020
Trinseo, a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber, announced the release of its 2020 Sustainability & Corporate Social Responsibility Report.
-
Dr. Michael Mina of the Harvard T.H. Chan School of Public Health, supported by TrialSpark, announces enrollment of first 500 patients of a COVID-19 serological surveillance study
7/21/2020
Dr. Michael Mina of the Harvard T. Chan School of Public Health announced the successful enrollment of the first 500 patients just 10 days after launching a COVID-19 longitudinal serological surveillance study using TrialSpark's Covalence trial platform.
-
Surgery Partners, Inc. Announces Second Quarter 2020 Earnings Release Date and Conference Call Details
7/21/2020
Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2020 results before the market opens on Wednesday, August 5, 2020,
-
BioNTech Announces Proposed Public Offerings
7/21/2020
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today the proposed public offerings described below. The completion of the proposed public offerings is subject to market and other factors. BioNTech announced the commencement of a firm commitment underwritten offering (the “Underwritten Offering”) of 5,000,000 American Depositary Shares (“ADSs”), each representing one of its ordinary shares. In connection with the Underwri
-
Cerecor Announces First Patient Enrolled in Multicenter Proof-of-Concept Study Evaluating CERC-002 for COVID-19 ARDSTop-line Data Anticipated in Fourth Quarter 2020
7/21/2020
Cerecor Inc. announced the first patient has been enrolled in a proof-of-concept trial evaluating the safety and efficacy of the anti-LIGHT monoclonal antibody, CERC-002, in patients with COVID-19 cytokine storm-induced Acute Respiratory Distress Syndrome.
-
Government of Canada announces creation of Essential Services Contingency Reserve through Safe Restart Agreement
7/21/2020
The Government of Canada is working to ensure that essential service organizations have access to the key supplies that they need to keep their members safe during COVID-19 as our economy reopens.
-
Acentrus Specialty Partners with Puma Biotechnology to Bring Nerlynx® (neratinib) to Health Systems and Hospitals in the Acentrus Network
7/21/2020
Acentrus Specialty™, a national network of health systems and hospitals committed to providing specialty pharmacy care for their patients, has finalized an agreement with Puma Biotechnology, Inc.
-
Prescient Announces Recent Appointments to the Advisory Senior Team
7/21/2020
Prescient hires two new senior members to support its fast-growing Advisory business
-
Sartorius With Dynamic Growth in the First Half; 2020 Sales and Earnings Forecast Raised
7/21/2020
Successful first half: Order intake1 up 27.5 percent, Group sales revenue up 17.9 percent, underlying EBITDA1 margin reaches 27.8 percent
-
vybe urgent care Re-opens in Bensalem
7/21/2020
With thorough precautions to minimize risk of COVID-19, patients can expect safe and personalized care.
-
Coronavirus (COVID-19) Update: Daily Roundup - July 21, 2020
7/21/2020
The U.S. Food and Drug Administration continued to take action in the ongoing response to the COVID-19 pandemic
-
Information Update - Certain hand sanitizers may pose health risks - July 21, 2020
7/21/2020
[21-July-2020] OTTAWA, ON , July 21, 2020 /CNW/ - Health Canada is advising Canadians that the following hand sanitizers made with ethanol or denaturants that are not acceptable for use in hand sanitizers, may pose health risks. Denaturants are added to ethanol to make it unfit for human consumption and, therefore, to avoid the unintentional ingestion of hand sanitizers (particularly by children
-
Corinth MedTech Announces Evaluation Program Of The Veloxion System
7/21/2020
Evaluations Signal Commercial Release of the Veloxion System in Q4 2020
-
Sage Therapeutics to Report Second Quarter 2020 Financial Results on Monday, August 10, 2020
7/21/2020
Sage Therapeutics, Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, announced it will host a live webcast on Monday, August 10, 2020, at 8:30 a.m. ET to announce second quarter 2020 financial results and discuss recent business updates.
-
Teckro Looks to Future on 5th Anniversary: Expands Leadership Team to Accelerate Growth
7/21/2020
Software veteran Amanda Buckley joins as Chief Operating Officer
-
Wyss Institute's tough gel technology licensed to Amend Surgical for oral surgery applications
7/21/2020
Medical device company will pursue development of strong, biocompatible adhesive that could replace sutures and dental membranes
-
Caris Precision Oncology Alliance Welcomes Montefiore Health System
7/21/2020
Montefiore Health System becomes the 39th member of the Caris collaborative network focused on expanding the application of precision medicine in oncology
-
Encompass Health declares dividend on common stock - July 21, 2020
7/21/2020
Encompass Health Corp. announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.28 per share, payable on Oct.